Genetic control of antibody responses induced by recombinant Mycobacterium bovis BCG expressing a foreign antigen.
Recombinant Mycobacterium bovis BCG expressing foreign antigens represents a promising candidate for the development of future vaccines and was shown in several experimental models to induce protective immunity against bacterial or parasitic infections. Innate resistance to BCG infection is under genetic control and could modify the immune responses induced against an antigen delivered by such engineered microorganisms. To investigate this question, we analyzed the immune responses of various inbred strains of mice to recombinant BCG expressing beta-galactosidase. These experiments demonstrated that BALB/c mice developed strong antibody responses against BCG expressing beta-galactosidase under the control of two different promoters. In contrast, C57BL/6, C3H, and CBA mice produced high anti-beta-galactosidase antibody titers only when immunized with recombinant BCG expressing beta-galactosidase under the control of the pblaF* promoter, which induced the production of high levels of this antigen. This difference in mouse responsiveness to recombinant BCG was not due to innate resistance to BCG infection, since similar immune responses were induced in Ity(r) and Ity(s) congenic strains of mice. In contrast, the analysis of anti-beta-galactosidase antibody responses of H-2 congenic mice in two different genetic backgrounds demonstrated that H-2 genes are involved in the immune responsiveness to beta-galactosidase delivered by recombinant BCG. Together, these results demonstrate that immune responses to an antigen delivered by recombinant BCG are under complex genetic influences which could play a crucial role in the efficiency of future recombinant BCG vaccines.
Lagranderie
M
M
Laboratoire du BCG, Institut Pasteur, Paris, France.
Lo-Man
R
R
Dériaud
E
E
Gicquel
B
B
Gheorghiu
M
M
Leclerc
C
C
D000818:Animals; D000907:Antibodies, Bacterial / Q000097:blood*; D001500:BCG Vaccine / Q000276:immunology*; D005260:Female; D006183:H-2 Antigens / Q000235:genetics; D007114:Immunization; D007371:Interferon-gamma / Q000096:biosynthesis; D051379:Mice; D008807:Mice, Inbred BALB C; D008809:Mice, Inbred C3H; D008810:Mice, Inbred C57BL; D009163:Mycobacterium bovis / Q000235:genetics; D013045:Species Specificity; D014614:Vaccines, Synthetic / Q000276:immunology*; D001616:beta-Galactosidase / Q000276:immunology*
D000907:Antibodies, Bacterial; D001500:BCG Vaccine; D006183:H-2 Antigens; D014614:Vaccines, Synthetic; D007371:Interferon-gamma; D001616:beta-Galactosidase